TechSandBox: MetroWest Innovation Hub 

Our Mission:   Deliver the comprehensive resources needed by Innovation-driven enterprises and their entrepreneurs, accelerating success by bringing the ecosystem together, right here in MetroWest.

Life Sciences SIG
3rd Monday of the Month
, unless there's a holiday, which happens a lot this year! We start food, networking and registration at 5:30p with program proceedings 6- 6:15p.  $25 up until a week before the program/ $30 until 2pm day of program/ $35 at door; Includes food. Members of this SIG are admitted free.

SIG SPONSORS:         Colliers supporters of TechSandBox Life Sciences SIG    


Our life sciences special interest group includes medical devices, cell biology, pharmaceutical development and medical records.


May 2 - Medical Robotics: What’s New and What’s Needed? with Gregory Fischer, PhD, Worcester Polytechnic Institute (WPI) and Ingolf Tuerk, MD, Chief of Urology, St. Elizabeth’s and professor of urology at Tufts University,

5:30PM food and networking; 6PM program

Applications of robots in the life sciences are growing as we develop better technology and as fear decreases! In addition, assistive technologies enable physicians to get better results with shorter surgery times – a win-win all around.

We are pleased to have Professor Greg Fischer, faculty at WPI, who is working with leading hospitals to deliver outcomes from the research in the WPI AIM Labs on medical robotics—the link that allows us to enable "closed loop medicine" by using real time feedback to guide a surgical procedure.

Dr. Ingolf Tuerk, head of urology at St. Elizabeth’s Medical Center in Boston joins our panel to talk about robotic surgical techniques with his pioneering work in laparoscopic surgery.

 Dr Ingolf Tuerk, St Elizabeth's at TechSandBox   Prof Greg Fischer, WPI

BIOS

Gregory Fischer, PhD, Worcester Polytechnic Institute (WPI), is an Associate professor at WPI in Mechanical Engineering and Robotics Engineering with an appointment in Biomedical Engineering. Dr. Fischer is also the Scientific Director of the WPI Healthcare Delivery institute and currently on sabbatical where he is visiting faculty in the Department of Radiology at Brigham and Women’s Hospital working with the Surgical Planning Laboratory. He received his PhD from Johns Hopkins University in Mechanical Engineering in 2008 and an MS in Electrical Engineering in 2005, where he was part of the NSF Engineering Research Center for Computer Integrated Surgery (ERC-CISST). He was instrumental in developing the Robotics Engineering undergraduate program at WPI as well as implementing the MS and PhD programs in Robotics. Dr. Fischer is Director of the WPI Automation and Interventional Medicine Robotics Research Laboratory (AIM Lab: http://aimlab.wpi.edu) where he leads research in various healthcare robotic systems including rehabilitation and surgery, with an emphasis on enabling technologies for MRI-guided robotic surgical interventions including fiber optic sensors, piezoelectric and pneumatic actuators, haptics and teleoperation, modular robot control systems, and application testbeds. Current research includes an MRI-compatible robotic system for image-guided conformal ablation of deep brain tumors, and a system currently in clinical trials for precision targeted MRI-guided prostate cancer biopsy.

Ingolf Tuerk, MD, Chief of Urology, St. Elizabeth’s and professor of urology at Tufts Univeristy, is a world-renowned laparoscopic and robotic urologic surgeon, Dr. Tuerk has performed 1,500 laparoscopic radical prostatectomies since 1999 and 2,500 robotic radical prostatectomies since 2006. He is responsible for pioneering several laparoscopic as well as robotic surgery techniques, including radical and partial nephrectomy, radical prostatectomy, right side donor nephrectomy and radical cystectomy with urinary diversion. In 2002 Dr. Tuerk joined the Institute of Urology at Lahey Clinic and as director for minimal invasive laparoscopic/robotic surgery and vice chairman he helped develop robust laparoscopic and robotic surgery programs. Since he joined St. Elizabeth’s in 2008, the hospital established one of New England’s premier robotic surgery programs with 700 - 800 robotic procedures performed annually. Dr. Tuerk received his medical degree from the medical school at Humboldt University in Berlin in 1989, after which he trained at the city’s Charite Hospital.


June 20: Life Sci SIG Technologies targeting neurological disorders or, I Sing the Body Electric

https://tech.memberclicks.net/index.php?option=com_mc&view=mc&mcid=form_217513

Neuromodulation has transformed from a research-only paradigm to a therapy with potential to change the entire approach to many human health problems. Targeted neuro-therapies may provide suppression of many issues with pain, depression, and other neurological effects, without the side effects of far less effectively targeted chemical therapies.

Neuromodulation approaches also can enhance many prosthetics, from visual to aural to mechanical.

For this program, we have two biomedical expert from Draper Labs to talk about the possibilities.

Moderated by Amy LaChappelle

  • Jim Moran, Technical Director, Draper/ DARPA  SUBNETS  (Systems-Based Neurotechnology for Emerging Therapies)  Project
  • John Lachapelle, Technical Director, Draper/ DARPA HAPTIX (Hand Proprioception and Touch) Project
  • Philip Parks, MD, Draper Labs, Program Manager, Biomedical Solutions, Neural Systems & Neurotechnologies

Neuromodulation has many meanings, but for the sense of this discussion has to do with enhancing or changing response of targeted portions of the neural system with directed electrical stimulation of close-by neurons.

Neuromodulation has transformed from a research-only paradigm to a therapy with potential to change the entire approach to many human health problems. Targeted neuro-therapies may provide suppression of many issues with pain, depression, and other neurological effects, without the side effects of far less effectively targeted chemical therapies.

Neuromodulation approaches also can enhance many prosthetics, from visual to aural to mechanical. DARPA has invested in approaches to both cortical (brain) and peripheral (limb) neuromodulation therapies in order to advance the state of the art more rapidly than existing commercial applications. Draper is involved in two of these DARPA projects, as well as a variety of other research in the neuromodulation space.

A top-down summary of general activities in the neuromodulation/ electroceutical space will be given. Then Jim and John will outline the DARPA goals for SUBNETS and HAPTIX (found on DARPA’s website) and how Draper hopes to advance the state of the art in implanted neuro-therapies. Though promising, the challenges with neuro-therapies include issue with electronic miniaturization in an implanted biological environment, use of software and algorithms in human targets, and basic understanding of how neurons operate (biologically) and communicate in networks.

Jim MOran, Draper Labs   Dr Philip Parks, Draper  John LaChapelle, Draper Labs

BIOS

John Lachapelle, Draper’s principal investigator for HAPTIX. Technical Director, Draper HAPTIX project. John has been involved in Draper-DARPA SUBNETS Project. His focus is circuits and systems for sensor and communications applications. I've worked together with strong innovators in MEMs and biomedical sensors, telemetry, and various WLAN, GPS, and land mobile communications. He holds several patents.

He has completed Biomedical Engineering studies at  Worcester Polytechnic Institute, and has MSEE University of Massachusetts, Amherst, BSEE University of Massachusetts at Lowell.

Jim Moran is Senior Member of Technical Staff at Draper Laboratory.  He is a member of the HDL Design and Verification group and specializes in the design of custom and embedded digital systems.  His recent work has centered on building an implantable neuromodulation device, miniature low-power communications systems using software defined radio and the design of telemetry and recharging systems for implanted medical devices.  Prior to joining Draper Laboratory, Mr. Moran held positions at a number of communications and computing companies.  

He received a BS (1983) and an MS (1986) in Electrical Engineering from the University of Massachusetts Lowell and an ALM (2013) in Biotechnology with a concentration in Bioengineering and Nanotechnologies from Harvard University.  Mr. Moran is an adjunct professor at University of Massachusetts Lowell and a Senior Member of the IEEE.

Dr. Philip Parks has more than 15 years of experience as clinician, scientist, leader, military officer, and strategic advisor with significant accomplishments in new business development, strategic advisement and scientific, engineering, and technical advisement on research, development, testing, and evaluation initiatives.

He joined Draper in early 2012 as a Distinguished Member of the Technical Staff (DMTS) and transitioned to Biomedical Solutions Program Office in the summer of  2013. As a DMTS, Dr. Parks was directly responsible for winning $5M in new projects and successfully executed engineering projects as a technical director and contributed as a technical advisor. In Biomedical Solutions, Dr. Parks has been directly responsible for new business development in neurotechnology programs ($17M in new business). He currently leads Draper’s neurotechnology portfolio including DARPA and NIH funded programs.

Prior to Draper, Dr. Parks was a consultant and SETA (Scientific Engineering Technical Assistant) for a federal government science and technology (S&T) office and was responsible for providing engineering management and scientific advisory functions for the S&T office’s neuroscience and neurotechnology portfolio.

Dr. Parks holds an Undergraduate degree from  Davidson College, Molecular Biology and Philosophy and attended Tulane University School of Medicine.  He is board certified and continues to be active in clinical practice.


Committee: Patti DurrPeter Allen, Jerry Shapiro, Mark Hediger, Amy LaChapelle, Carmel Denis, Howard Lin

Co-Chairs, Jerry Shapiro and Barbara Finer
Contact our Chair with questions or if you want to volunteer in some capacity (Jerrold)

    Medical Devices, to Biotech, to Pharma and Cell Biology, to eMR, imaging, medical robotics, 510K, FDA   Jerrold Shapiro, PhD FemMedical   Peter Allen  Patti Durr, Tri-Star Design  Carmel Denis, Medical Device project managemet  Amy LaChappelle, QBD  Mark Hediger, MEH                    


 

 


(C) TechSandBox™ Inc. 105B South Street Hopkinton, MA 01748 508-485-7263